
West Pharmaceutical Services WST
$ 266.92
-2.06%
Quarterly report 2025-Q3
added 10-23-2025
West Pharmaceutical Services DIO Ratio 2011-2025 | WST
Annual DIO Ratio West Pharmaceutical Services
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78.2 | 85.2 | 82.7 | 77.1 | 73.7 | 69.7 | 66.8 | 72.3 | 72.2 | 70 | 68 | 69.2 | 67.4 | 65 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 85.2 | 65 | 72.7 |
Quarterly DIO Ratio West Pharmaceutical Services
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76.8 | 75 | 75 | - | 77.6 | 82.1 | 84.8 | - | 87.6 | 88.5 | 88.3 | - | 45 | 42.2 | 83.3 | - | 76.2 | 73.2 | 72.2 | - | 83 | 88.3 | 78.3 | - | 69.8 | 69 | 69.2 | - | 66.1 | 64.1 | 69.7 | - | 71.9 | 72 | 74.6 | - | 71.2 | 71.4 | 72.7 | - | 70 | 68.4 | 73.1 | - | 67.3 | 67 | 68 | - | 68.3 | 69.1 | 68 | - | 69.4 | 65.5 | 66.6 | - | 65.3 | 62 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 88.5 | 42.2 | 72 |
DIO Ratio of other stocks in the Medical instruments industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Baxter International
BAX
|
109 | $ 18.99 | 0.48 % | $ 9.68 B | ||
|
Becton, Dickinson and Company
BDX
|
119 | $ 200.87 | 0.22 % | $ 57.8 B | ||
|
BioLife Solutions
BLFS
|
457 | $ 24.43 | -1.81 % | $ 1.13 B | ||
|
Luminex Corporation
LMNX
|
265 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
66.1 | - | -9.52 % | $ 20.6 M | ||
|
Ekso Bionics Holdings
EKSO
|
209 | $ 4.79 | 2.35 % | $ 96.6 M | ||
|
DENTSPLY SIRONA
XRAY
|
118 | $ 11.59 | -0.13 % | $ 2.36 B | ||
|
Antares Pharma, Inc.
ATRS
|
105 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
106 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
0.917 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
91.4 | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
105 | - | -0.02 % | $ 16.3 B | ||
|
Alcon
ALC
|
126 | $ 78.74 | -0.03 % | $ 40.4 B | ||
|
iRhythm Technologies
IRTC
|
27.7 | $ 170.09 | 0.58 % | $ 5.31 B | ||
|
AtriCure
ATRC
|
222 | $ 42.08 | 1.62 % | $ 1.98 B | ||
|
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | ||
|
electroCore
ECOR
|
270 | $ 4.81 | -0.21 % | $ 26.5 K | ||
|
Harvard Bioscience
HBIO
|
202 | $ 0.76 | 1.78 % | $ 32.2 M | ||
|
AngioDynamics
ANGO
|
166 | $ 13.12 | -2.42 % | $ 536 M | ||
|
The Cooper Companies
COO
|
213 | $ 81.82 | -0.36 % | $ 16.3 B | ||
|
ICU Medical
ICUI
|
152 | $ 147.72 | 0.34 % | $ 3.6 B | ||
|
Glaukos Corporation
GKOS
|
193 | $ 109.57 | 0.31 % | $ 5.31 B | ||
|
Haemonetics Corporation
HAE
|
204 | $ 83.2 | -1.49 % | $ 4.19 B | ||
|
InfuSystem Holdings
INFU
|
33.8 | $ 9.24 | 0.33 % | $ 191 M | ||
|
Isoray
ISR
|
94.7 | - | 0.03 % | $ 108 M | ||
|
Repro Med Systems
KRMD
|
153 | $ 5.75 | -1.88 % | $ 262 M | ||
|
LeMaitre Vascular
LMAT
|
338 | $ 83.51 | 0.18 % | $ 1.87 B | ||
|
Intuitive Surgical
ISRG
|
182 | $ 541.3 | -1.11 % | $ 192 B | ||
|
Masimo Corporation
MASI
|
168 | $ 138.1 | -2.25 % | $ 7.36 B | ||
|
Merit Medical Systems
MMSI
|
156 | $ 86.52 | -0.01 % | $ 5.04 B | ||
|
Milestone Scientific
MLSS
|
528 | $ 0.39 | 9.69 % | $ 31.1 M | ||
|
Nephros
NEPH
|
176 | $ 5.08 | 2.24 % | $ 52.8 M | ||
|
NeuroMetrix
NURO
|
392 | - | 5.05 % | $ 9.02 M | ||
|
ResMed
RMD
|
141 | $ 250.7 | -0.67 % | $ 36.6 B | ||
|
Envista Holdings Corporation
NVST
|
80.2 | $ 21.79 | -1.58 % | $ 3.75 B | ||
|
OraSure Technologies
OSUR
|
140 | $ 2.52 | -2.14 % | $ 188 M | ||
|
Pro-Dex
PDEX
|
145 | $ 43.83 | 0.6 % | $ 144 M | ||
|
Pulse Biosciences
PLSE
|
89 | $ 14.26 | 3.71 % | $ 685 M | ||
|
Predictive Oncology
POAI
|
191 | $ 5.95 | 0.51 % | $ 32.4 M | ||
|
Repligen Corporation
RGEN
|
227 | $ 156.65 | -3.1 % | $ 8.73 M | ||
|
Retractable Technologies
RVP
|
197 | $ 0.83 | -0.31 % | $ 24.8 M | ||
|
STAAR Surgical Company
STAA
|
164 | $ 24.16 | -2.11 % | $ 1.19 B | ||
|
STERIS plc
STE
|
75 | $ 251.01 | -0.59 % | $ 24.7 B | ||
|
Stereotaxis
STXS
|
250 | $ 2.38 | -1.45 % | $ 192 M | ||
|
Teleflex Incorporated
TFX
|
166 | $ 125.81 | -1.13 % | $ 5.89 B | ||
|
Utah Medical Products
UTMD
|
166 | $ 57.99 | 0.5 % | $ 210 M |